A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissues: implications for the molecular diagnosis of minimal disease in rhabdomyosarcomas.
about
A human recombinant autoantibody-based immunotoxin specific for the fetal acetylcholine receptor inhibits rhabdomyosarcoma growth in vitro and in a murine transplantation model.Conotoxins targeting nicotinic acetylcholine receptors: an overviewDetection of bone marrow micrometastasis and microcirculating disease in rhabdomyosarcoma by a real-time RT-PCR assay.Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcomaMyogenin and MyoD1 expression in paediatric rhabdomyosarcomas.Molecular genetics of pediatric soft tissue tumors: clinical application.Molecular biology of rhabdomyosarcoma.Establishment of novel human dedifferentiated chondrosarcoma cell line with osteoblastic differentiation.Targeting the fetal acetylcholine receptor in rhabdomyosarcoma.PAX--FKHR fusion genes and AChR-gamma in Chinese patients with rhabdomyosarcoma: diagnosis using formalin-fixed archival tissues.Isolation, detection, and immunomorphological characterization of circulating tumor cells (CTCs) from patients with different types of sarcoma using isolation by size of tumor cells: a window on sarcoma-cell invasion.Expression of foetal type acetylcholine receptor is restricted to type 1 muscle fibres in human neuromuscular disorders.Detection and clinical significance of bone marrow involvement in patients with rhabdomyosarcoma.Peptide-toxin tools for probing the expression and function of fetal and adult subtypes of the nicotinic acetylcholine receptor.Survivin blockade sensitizes rhabdomyosarcoma cells for lysis by fetal acetylcholine receptor-redirected T cells.
P2860
Q33692521-C6DC3FBA-29F3-4DDE-81FB-93F4A56CA3CEQ33736765-3D23C006-159D-4CA6-BC4D-647E4E29C262Q34487874-9D1E9A20-FF18-41C9-8DD6-CCB929218225Q34580128-2560712F-3821-4AB9-82E7-160892B03474Q35144171-B7BED485-6208-4E95-85D2-F4B26AE8AC8EQ35183100-5587C3D9-7693-4EC7-88E9-A21FFACE5509Q36891362-EDDC9635-020B-464F-A92A-57733034EF50Q36892224-AA5B5CE4-32E7-469C-87FA-32D2386D14A2Q38066542-F9BC98A3-88E3-4CB6-9801-A2AC3ABB12BDQ38424287-C4A1F9CE-1E78-4D5B-8B93-8CF9FD5CBA06Q42036216-13464FB4-A236-4244-B1DC-2B1531F542B5Q44002205-F0509D44-79F7-4C19-82BC-29BEECB4874DQ44161513-B51F5A0C-C0C4-4603-8295-ECB74DE98609Q46528826-7088A121-D11C-46BD-8C1D-3545CB8CC5BCQ47112233-0A00B65F-9004-42B0-96EF-4D87829326B6
P2860
A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissues: implications for the molecular diagnosis of minimal disease in rhabdomyosarcomas.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
A comparison of MyoD1 and feta ...... disease in rhabdomyosarcomas.
@ast
A comparison of MyoD1 and feta ...... disease in rhabdomyosarcomas.
@en
type
label
A comparison of MyoD1 and feta ...... disease in rhabdomyosarcomas.
@ast
A comparison of MyoD1 and feta ...... disease in rhabdomyosarcomas.
@en
prefLabel
A comparison of MyoD1 and feta ...... disease in rhabdomyosarcomas.
@ast
A comparison of MyoD1 and feta ...... disease in rhabdomyosarcomas.
@en
P2093
P2860
P1476
A comparison of MyoD1 and feta ...... disease in rhabdomyosarcomas.
@en
P2093
B Dockhorn-Dworniczak
H K Müller-Hermelink
I Leuschner
S Gattenloehner
P2860
P356
10.1016/S1525-1578(10)60605-8
P577
1999-11-01T00:00:00Z